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INTRODUCTION
Surgeons are increasingly challenged by opportunistic fun-
gal infections. During the last four decades, the incidence of
invasive opportunistic fungal infections has risen dramati-
cally (1). Aspergillus species are ubiquitous molds that are
easily isolated from air, soil, decaying vegetation, and dust.
These species are the second-most common cause of oppor-
tunistic fungal infections, surpassed only by Candida species
(2). Cutaneous aspergillosis is a rare form of a locally inva-
sive disease. It generally enters through breaks in the skin,
colonizing burns, surgical wounds, or intravenous catheter
sites, and subsequently invades viable tissue. Human beings
are constantly exposed to this organism, which results in
frequent colonization. Cutaneous aspergillosis is most com-
monly seen in immunocompromised hosts; however, only
rarely does Aspergillus behave as a pathogen in an immuno-
competent host (2, 3). 
Despite the advent of efficacious antimicrobial therapy,
combined surgical therapy is still advocated. There could be
various surgical therapeutic methods: incision and drainage of
abscesses, fistulotomy, sinus tract excision, and more exten-
sive debulking of infected tissue with skin graft or flap cov-
erage are recommended. To the best of our knowledge, this
is the first report of flap reconstruction of cutaneous aspergillo-
sis. Therefore, we report our clinical experience with a review
of the relevant literature (1, 4).
CASE REPORT
A 45-yr-old man presented with a painful ulcerative lesion
on his right elbow. The patient had been treated for herpes
zoster 4 yr before and erythematous 1-cm sized painful nod-
ule was noted on his upper arm in the following years. His
past medical history was not specific and he had worked as a
carpenter for 20 yr. The nodular lesion developed into ulcer-
ative lesion pregressively and finally became a dry, black,
escharous lesion with a maximal diameter of 6 cm (Fig. 1).
The surrounding skin was erythematous. Neither purulence
nor odor was noted, and no localized axillary or generalized
lymphadenopathy was observed. Laboratory studies revealed
unspecific results, except a mildly elevated white blood cell
count. The patient did not exhibit any sensory or motor deficits
in his upper extremities, although movement resulted in inter-
mittent pain.
Three-dimensional (3-D) upper extremity computed tomo-
graphic (CT) angiography of the lesion revealed a skin defect
at the posterolateral aspect of the distal humerus and a low
attenuated lesion 3 cm in size that was located intramuscu-
larly and showed rim enhancement. A candidate recipient
artery, a 1-2 mm-sized branch of the brachial artery, was
marked. Magnetic resonance imaging (MRI) examination
showed a chronic inflammatory change of the skin at the
subcutaneous fat defect portion and infectious myositis at
the triceps muscle (Fig. 2). The possibility of squamous cell
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Free Flap Coverage of Extensive Soft Tissue Defect in Cutaneous
Aspergillosis: A Case Report
Isolated fungal soft-tissue infections are uncommon, but may cause severe morbid-
ity or mortality. Aspergillosis infection is rare, but the frequency in increasing over
the last two decades. Here, we present a patient with cutaneous aspergillosis of
his right elbow with unusual clinical and radiological features suggestive of a malig-
nant disease, which remained undiagnosed for an extended period of time. The
patient presented with necrotic, black-colored skin ulcerations. We completely
removed the skin ulcer with the surrounding erythematous skin lesion, and then
we reconstructed the area with thoracodorsal perforator free flap. The biopsy speci-
men contained septate hyphae with dichotomous branching, which is morphologi-
cally consistent with a finding of Aspergillus. After surgery, we initiated antifungal
medication therapy with amphotericin B and itraconazole. At the time of follow-up,
the elbow with the reconstructed flap had fully healed, and no recurrent disease
was found.
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carcinoma could not be ruled out. Diagnostic skin punch
biopsy demonstrated chronic active inflammation with ulcer-
ation and necrosis with regenerating epithelia, but failed to
show any microorganism on direct microscopy or in culture.
We planned surgical resection of the necrotic skin ulcer and
free flap coverage. The necrotic and infected central tissue
extending into the subcutaneous fat was removed, and a 2-3
cm rim of non-necrotic, erythematous skin was also removed
as the surgical margin (Fig. 3). The lateral side of the triceps
muscle and periosteum was also partially excised. No bony
involvement was seen on the gross view but elbow joint exter-
nal capsule was exposed. The wound bed was severely scarred
owing to chronic inflammation. We dissected the profunda
brachii artery and the vein between the biceps and triceps
brachii muscles as a recipient vessel. After identification of
Fig. 1. Primary cutaneous aspergillosis of the elbow. Note the
open weeping ulcers, black necrotic eschars, and diffuse erythe-
matous skin changes.
Fig. 2. Magnetic resonance imaging (fat saturated T1-enhancing)
examination showed a soft tissue defect and severe muscular
inflammatory infiltration around bone.
Fig. 3. The surrounding 2-3 cm margin of non-necrotic, erythe-
matous skin was removed with central ulceration.
Fig. 4. A periodic acid-Schiff stained section of necrotic lesion.
Septate hyphae are surrounded by dermal necrosis and acute
inflammation (original magnification, ×40). 922 C.Y. Heo, S.C. Eun, R.M. Baek, et al.
the perforator using Doppler sound, a 13×8 cm-sized ipsi-
lateral thoracodorsal perforator flap was designed and elevat-
ed. After flap transfer, we performed arterial microanastomo-
sis first between the radial collateral artery and thoracodor-
sal artery. Finally, we did venous anastomosis between each
of vena commitantes.
One week postoperatively, permanent pathology with
Gomori methenamine silver (GMS) and periodic acid-Schiff
(PAS) staining confirmed chronic active inflammation and
extensive necrosis with numerous fungal hyphae showing
septation and branching consistent with Aspergillus species
(Fig. 4, 5). Tissue cultures grew A. fumigatus. After surgery,
the patient was started on amphotericin B (20 mg/day) IV
for 5 days and switched to oral itraconazole (200 mg q 12 hr)
medication. The wound went on to heal satisfactorily, and
there has been no evidence of recurrent disease at 2 yr of fol-
low-up (Fig. 6).
DISCUSSION
All Aspergillus species are molds, which together with
yeasts are classified as fungi. Aspergillosis is the second-most
frequent opportunistic infection, surpassed only by candidi-
asis (1, 3, 4). There are more than 1,000 species of Aspergillus,
but A. fumigatus is the most common cause of colonization
and invasive aspergillosis (2, 3). A. fumigatus rarely behaves
as a pathogen in an immunocompetent host; however, in an
immunocompromised host, it may be invasive and may take a
fulminant course. Cutaneous aspergillosis may be primary or
secondary to systemic dissemination. It presents as erythema-
tous papules or plaques that evolve into necrotic skin lesions,
often at sites of skin trauma associated with intravenous cathe-
ters and placement of adhesive tape or monitor leads, or at
sites of surgical or other traumas (5, 6). If hyphae are some-
how able to develop, functioning neutrophils remove them
efficiently. If these host defenses fail, infection may develop.
The prompt recognition and appropriate treatment of cuta-
neous fungal disease is critical to the prevention of adverse
outcomes, but aspergillosis poses some unique diagnostic
and therapeutic challenges. Skeletal aspergillosis usually con-
flicts with neoplastic or inflammatory diseases. Radiograph-
ic studies may be helpful, but not confirmatory. Aspergillo-
sis may initially present to the clinician as a painful and locally
destructive lesion. The typical lesion is an erythematous (or
violaceous), edematous, indurated papule or nodule that pro-
gresses to a blue-black necrotic ulcer with a black eschar due
to regular invasion into blood vessels, causing local throm-
bosis and hemorrhage (2-5). Tissue biopsy with special stains
and tissue culture are the preferred methods for the diagno-
sis of aspergillosis. Fungal hyphae can be seen in hematoxylin-
eosin-stained sections, but staining with periodic acid-Schiff
or Gomori methenamine silver highlights their morpholog-
ical characteristics, as in our case (2-4). 
Treatment of cutaneous aspergillosis includes a combina-
tion of surgical debridement and multi-drug antifungal
chemotherapy. Amphotericin B, often in combination with
flucytosine, is considered the first-line therapy. Then a switch
to itraconazole (or voriconazole) oral medication for several
months is a recent trend of drug therapy. Itraconazole has
some disadvantage of gastrointestinal trouble and unpredic-
Fig. 5. Gomori methenamine silver stain (GMS) of the lesion reveals
numerous spores and hyphae with a morphology consistent with
aspergillosis (original magnification, ×40). 
Fig. 6. A postoperative 2 yr view shows a completely healed flap
coverage area.Free Flap Reconstruction in Cutaneous Aspergillosis 923
table outcome. If patients do not respond to oral itracona-
zole therapy, serum itraconazole levels must be checked to
ensure therapeutic dosages, and cultures checked for sensi-
tivity to itraconazole (2-5). 
Despite the advent of efficacious antimicrobial therapy,
combined surgical therapy is still advocated (5-7). Surgical
treatment ranges from simple excision to radical debridr-
ment. Simple, reliable coverage should be the goal for debili-
tated patients with multisystem dysfunction (coagulation
factors, steroids, immunosuppression, anemia, malnutrition,
etc.). Skin grafting, healing by secondary intention, and local
flaps are the safest, most reliable choices in this compromised
population (8-10). Our patient was relatively healthy, and
the wound demanded free flap coverage as a treatment choice
in the aspects of defect size and depth. Our case is unique in
the cutaneous fungal infections, and suggests that free flap
coverage could be a useful addition to the therapeutic arse-
nal in select cases of extensive cutaneous fungal infections.
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